Read Online THE POLITICS OF PLEASURE by Mark Russell - Free Book Online
Authors: Mark Russell
Ads: Link
bedside clock/radio and nestled against propped pillows. He shuffled together the twenty-odd pages he'd copied from the Silverwood computer. He took a deep breath and read the synopsis of a CIA project in the early fifties.
SUBJECT ONE: MK-ULTRA PROJECT
(INCORPORATING SUB-BRANCH CRYPTONYMS:
MK-DELTA, BLUEBIRD AND ARTICHOKE)
RESEARCH AND DEVELOPMENT IN THE CONTROL AND DIRECTION OF HUMAN BEHAVIOUR THROUGH BIOCHEMICAL PROCEDURES.
A PRELIMINARY SYNOPSIS BY J. A. HUGHES, PhD.
MARCH 21, 1962.
As acting Director of Central Intelligence, General Alexander Dulles approved the formation of Project MK-ULTRA on April 13, 1953.
Pan American Developments authorized $300,000 for initial project funding. MK-ULTRA was to fund and develop projects involving the use of biochemicals in classified military operations.
The principal reason behind the formation of the project and its sub-branches was the Soviet Union's purchase order for five kilograms (fifty-million human doses) of lysergic acid diethylamide (LSD) from Sandoz Pharmaceuticals in Switzerland in November 1952.
The Central Intelligence Agency (CIA) commissioned Dr. Gottchalk's Washington think tank to deduce the motivation behind the Soviet purchase order, and to recommend an appropriate retaliatory response.
The Gottchalk Commission construed the Soviet order as a first step in stockpiling unconventional weaponry that could be used against the United States at an undisclosed juncture. The Gottchalk Commission recommended the following procedures as an appropriate retaliatory response:
a) The immediate issuance of a National Security D Notice upon Sandoz Pharmaceuticals, to effectively override and nullify the existing Soviet purchase order, in compliance with and utilization of Section 102 of the National Security Act of 1947.
b) The immediate issuance of a US purchase order upon Sandoz Pharmaceuticals for twice the amount of LSD as that ordered by the Soviet Union.
c) The immediate formation of a large umbrella project to fund the development of hallucinogens and neuroactive compounds, and to stockpile these chemical agents as a counter measure against Soviet application of similar substances ...
Goldman stopped reading and rubbed his eyes. Who could have imagined that shortly after World War Two his adoptive country had cornered the world supply of an unknown drug called LSD. Sandoz Pharmaceuticals? He stroked his chin and recalled a medical journal article he'd read at university. If he remembered rightly, Dr. Hoffman accidentally discovered LSD at the Sandoz laboratory in the early forties. As a fellow chemist Goldman empathized with Hoffman. He imagined how aggrieved the Swiss chemist must have been when the superpowers scrambled to use the hallucinogen for offensive cold war applications. Ah well, he thought, it wasn't the first time military agencies had railroaded an obscure discovery for questionable ends.
He glanced at his watch, picked up a remote, and turned on the portable TV resting on a small wheeled table at the foot of his bed. He turned up the volume as the nine-thirty finance report began. Four months earlier, Goldman had bought thirty gold coins: one-ounce Krugerrands. After the massive three hundred and thirty dollar drop in the gold price at the start of the year, his stockbroker had predicted the bullion price had nowhere to go but up. After hearing the day's quotation for the Dow Jones Industrial Average, he looked to the screen for the London and New York spot bullion prices.
Three hundred dollars profit, he roughly calculated. So much for my excursion into the world of high-finance. Hmm, least I'm ahead. He turned off the TV and grabbed his bedside phone. Humming to a Marvin Gaye song on the radio, he tapped the phone's buttons.
Belize Cheraz lit a stick of incense. She blew out the quivering yellow-green flame and pushed the perfumed stick into a blob of Plasticine on the shelf above her bathroom sink. The shapely Cuban-exile inhaled
SUBJECT ONE: MK-ULTRA PROJECT
(INCORPORATING SUB-BRANCH CRYPTONYMS:
MK-DELTA, BLUEBIRD AND ARTICHOKE)
RESEARCH AND DEVELOPMENT IN THE CONTROL AND DIRECTION OF HUMAN BEHAVIOUR THROUGH BIOCHEMICAL PROCEDURES.
A PRELIMINARY SYNOPSIS BY J. A. HUGHES, PhD.
MARCH 21, 1962.
As acting Director of Central Intelligence, General Alexander Dulles approved the formation of Project MK-ULTRA on April 13, 1953.
Pan American Developments authorized $300,000 for initial project funding. MK-ULTRA was to fund and develop projects involving the use of biochemicals in classified military operations.
The principal reason behind the formation of the project and its sub-branches was the Soviet Union's purchase order for five kilograms (fifty-million human doses) of lysergic acid diethylamide (LSD) from Sandoz Pharmaceuticals in Switzerland in November 1952.
The Central Intelligence Agency (CIA) commissioned Dr. Gottchalk's Washington think tank to deduce the motivation behind the Soviet purchase order, and to recommend an appropriate retaliatory response.
The Gottchalk Commission construed the Soviet order as a first step in stockpiling unconventional weaponry that could be used against the United States at an undisclosed juncture. The Gottchalk Commission recommended the following procedures as an appropriate retaliatory response:
a) The immediate issuance of a National Security D Notice upon Sandoz Pharmaceuticals, to effectively override and nullify the existing Soviet purchase order, in compliance with and utilization of Section 102 of the National Security Act of 1947.
b) The immediate issuance of a US purchase order upon Sandoz Pharmaceuticals for twice the amount of LSD as that ordered by the Soviet Union.
c) The immediate formation of a large umbrella project to fund the development of hallucinogens and neuroactive compounds, and to stockpile these chemical agents as a counter measure against Soviet application of similar substances ...
Goldman stopped reading and rubbed his eyes. Who could have imagined that shortly after World War Two his adoptive country had cornered the world supply of an unknown drug called LSD. Sandoz Pharmaceuticals? He stroked his chin and recalled a medical journal article he'd read at university. If he remembered rightly, Dr. Hoffman accidentally discovered LSD at the Sandoz laboratory in the early forties. As a fellow chemist Goldman empathized with Hoffman. He imagined how aggrieved the Swiss chemist must have been when the superpowers scrambled to use the hallucinogen for offensive cold war applications. Ah well, he thought, it wasn't the first time military agencies had railroaded an obscure discovery for questionable ends.
He glanced at his watch, picked up a remote, and turned on the portable TV resting on a small wheeled table at the foot of his bed. He turned up the volume as the nine-thirty finance report began. Four months earlier, Goldman had bought thirty gold coins: one-ounce Krugerrands. After the massive three hundred and thirty dollar drop in the gold price at the start of the year, his stockbroker had predicted the bullion price had nowhere to go but up. After hearing the day's quotation for the Dow Jones Industrial Average, he looked to the screen for the London and New York spot bullion prices.
Three hundred dollars profit, he roughly calculated. So much for my excursion into the world of high-finance. Hmm, least I'm ahead. He turned off the TV and grabbed his bedside phone. Humming to a Marvin Gaye song on the radio, he tapped the phone's buttons.
Belize Cheraz lit a stick of incense. She blew out the quivering yellow-green flame and pushed the perfumed stick into a blob of Plasticine on the shelf above her bathroom sink. The shapely Cuban-exile inhaled
Similar Books
